Trade Summary

2 days ago, Champoux Jennifer, serving as Chief Operating Officer at Monte Rosa Therapeutics, Inc. (GLUE), sold 4,351 shares at $23.38 per share, for a total transaction value of $101,729.86. Following this transaction, Champoux Jennifer now holds 62,371 shares of GLUE.

This sale represents a 6.52% decrease in Champoux Jennifer's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 4:10 PM ET, 1 day after the trade was made.

Monte Rosa Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.